Patents by Inventor Mohammad Jalalian

Mohammad Jalalian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6548469
    Abstract: The present invention relates to cleaning compositions which comprise the insect repellent ethyl 3-(N-butylacetamino)propionate and the use of this insect repellent in all types of cleaning compositions for repelling insects. This invention furthermore relates to a method for cleaning and for simultaneously repelling insects in which cleaning compositions comprising ethyl 3-(N-butylacetamino)propionate are used.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: April 15, 2003
    Assignee: Merck Patent GmbH
    Inventors: Mohammad Jalalian, Maria Elisabeth Prenzel, Roland Martin, Francesc Rosell I Oller
  • Publication number: 20020183234
    Abstract: The present invention relates to cleaning compositions which comprise the insect repellent ethyl 3-(N-butylacetamino)propionate and the use of this insect repellent in all types of cleaning compositions for repelling insects. This invention furthermore relates to a method for cleaning and for simultaneously repelling insects in which cleaning compositions comprising ethyl 3-(N-butylacetamino)propionate are used.
    Type: Application
    Filed: June 11, 2002
    Publication date: December 5, 2002
    Applicant: Merck Patent GmbH
    Inventors: Mohammad Jalalian, Maria Elisabeth Prenzel, Roland Martin, Francesc Rosell I Oller
  • Patent number: 6306905
    Abstract: The present invention relates to stable aqueous formulations of the insect repellent ethyl 3-(N-butyl-acetamino)propionate.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: October 23, 2001
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Thekla Kurz, Sabine Hitzel, Dorothee Wille, Mohammad Jalalian
  • Patent number: 5399672
    Abstract: The invention relates to a novel process for preparing immunoconjugates consisting of haptens which are sparingly soluble or insoluble in aqueous solution and proteins/polypeptides using special solvents, in particular diethylene glycol monoalkyl ethers.
    Type: Grant
    Filed: November 23, 1993
    Date of Patent: March 21, 1995
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Mohammad Jalalian, Arnulf Heubner, Bernd Reckmann